This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Spinogenix, Inc.. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Vincent F. Simmon: Innovator in Neuroprotective Compounds
Introduction
Vincent F. Simmon is a notable inventor based in San Diego, California. He has made significant contributions to the field of neuroprotective compounds, holding two patents that focus on improving brain health. His work is particularly relevant in addressing conditions related to neural toxicity and traumatic brain injury.
Latest Patents
Vincent's latest patents include innovative compounds that promote spinogenesis. These compounds are capable of reducing the neural toxicity of beta-amyloid peptides, which are associated with neurodegenerative diseases. Additionally, they aim to alleviate the symptoms of traumatic brain injury in patients, showcasing the potential for therapeutic applications in neurology.
Career Highlights
Vincent is currently associated with Spinogenix, Inc., a company dedicated to advancing research in neuroprotective therapies. His work at Spinogenix has positioned him as a key player in the development of treatments that could significantly impact patient outcomes in neurological health.
Collaborations
Vincent collaborates with talented individuals such as Stella Sarraf and Gerald F. Swiss. Their combined expertise enhances the research and development efforts at Spinogenix, fostering an environment of innovation and discovery.
Conclusion
Vincent F. Simmon's contributions to the field of neuroprotective compounds highlight his commitment to advancing medical science. His patents reflect a dedication to improving the lives of individuals affected by neurological conditions.